Rabdomyolysis as a serious complication of COVID-19
Rhabdomyolysis is an acute condition with skeletal muscle damage and release of toxins produced by myocytes with variable clinical presentation. Laboratory diagnosis is based on an increase in serum creatine phosphokinase (CPK), which can trigger irreversible renal impairment. The aim was to describ...
Main Authors: | Uri Adrian Prync Flato, Karina Vilariço Ferreira, Piero Biteli, Daniela Ortega Balbo Rodrigues Reina, Fábio Tadeu Rodrigues Reina, Fausto Tucunduva Vernaschi, Gabriela Achete de Souza, Gyovanna Sorrentino dos Santos Campanari, Júlia Novaes Matias, Vinícius Marinho Lima, Tereza Lais Menegucci Zutin, Rogério Leone Buchaim, Daniela Vieira Buchaim, Sandra Maria Barbalho |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2021-04-01
|
Series: | AIMS Bioengineering |
Subjects: | |
Online Access: | https://www.aimspress.com/article/doi/10.3934/bioeng.2021015?viewType=HTML |
Similar Items
-
An unexpected and devastating adverse event of dasatinib: Rhabdomyolysis
by: Burak Uz, et al.
Published: (2016-01-01) -
Late onset rhabdomyolysis developing secondary to atorvastatin therapy in a coronary artery disease patient
by: Somak Kumar Das, et al.
Published: (2015-01-01) -
Rhabdomyolysis with myoglobin-induced acute kidney injury: A case series of four cases
by: Hanock Unni Samuel, et al.
Published: (2021-01-01) -
Defining the Normal Trends of Serum Creatine Kinase Levels Following Spinal Surgery
by: Matthew Griffith, et al.
Published: (2019-06-01) -
Severe rhabdomyolysis and acute renal failure secondary to use of simvastatin in undiagnosed hypothyroidism
by: Qari Faiza
Published: (2009-01-01)